Advertisement
Screener

Pictet Asset Management Holding SA Historic Quarter Change: Foreign ADRs, Added

Pictet Asset Management Holding SA historic quarter change: Foreign ADRs, Added

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 10 quarters from 2023-12-31 to 2026-06-30, Pictet Asset Management Holding SA opened 3 positions, added to 6, reduced 12 and sold out of 7.

  • Q1 2026: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 73,418.
  • Q1 2025: Stock POLESTAR AUTOMOTIVE HLDG UK; Country of operation —; Class ADS A; Shares before 95,555.
  • Q3 2024: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 146,327.
  • Q2 2024: Stock SEQUANS COMMUNICATIONS S A; Country of operation —; Class SPONSORED ADS; Shares before 871,711.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1993888), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-07-30); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-04-22); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-01-29); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-18); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-13); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-05); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-12); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-12); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-13); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2023-09-30.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2026ASCENDIS PHARMA A/S
CUSIP 04351P101
SPONSORED ADR73,418251,833+178,415$15,492,666$56,906,562+$41,413,8962026-04-22
Q1 2025POLESTAR AUTOMOTIVE HLDG UK
CUSIP 731105201
ADS A95,555125,728+30,173$100,333$132,014+$31,6812025-05-05
Q3 2024ASCENDIS PHARMA A/S
CUSIP 04351P101
SPONSORED ADR146,327154,044+7,717$19,956,076$22,277,843+$2,321,7672024-11-12
Q2 2024SEQUANS COMMUNICATIONS S A
CUSIP 817323207
SPONSORED ADS871,711999,463+127,752$335,609$502,530+$166,9212024-08-13
Q1 2024ASCENDIS PHARMA A/S
CUSIP 04351P101
SPONSORED ADR203,654270,770+67,116$25,650,221$40,932,301+$15,282,0802024-05-14
Q1 2024SEQUANS COMMUNICATIONS S A
CUSIP 817323207
SPONSORED ADS427,322871,711+444,389$1,209,321$335,609-$873,7122024-05-14

Similar Firms

Firm NameCountry13F ValueHoldings
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEMUnited States$94.491B2,925
Swedbank ABSweden$95.149B1,062
HighTower Advisors, LLCUnited States$94.219B3,796
Allianz Asset Management GmbHGermany$95.382B3,758
Boston PartnersUnited States$95.467B1,772
Cetera Investment AdvisersUnited States$94.005B4,790
VOYA INVESTMENT MANAGEMENT LLCUnited States$96.096B3,717
Russell Investments Group, Ltd.United States$93.066B24,600
BAILLIE GIFFORD & COUnited Kingdom$97.893B906
Qube Research & Technologies LtdUnited Kingdom$89.928B3,481